01 · Botanical
Plant
Tabernanthe iboga is an Apocynaceae shrub whose underground root system concentrates relevant alkaloids after years of growth.
Independent plant-to-compound guide
What Is Ibogaine Made From? Plant To Compound
Ibogaine begins as a naturally occurring indole alkaloid in a Central African shrub, then becomes a defined compound only through controlled extraction, purification, or laboratory synthesis.
This resource explains origin, chemistry, and evidence without presenting ibogaine as an established treatment or providing an extraction recipe.
The short answer begins underground.
Ibogaine is primarily associated with the root bark of Tabernanthe iboga, a rainforest shrub indigenous to Central Africa. The path from living plant to pharmaceutical-style material is a sequence of botanical, chemical, and safety decisions.
That distinction matters. Raw bark is plant material containing many alkaloids. A total alkaloid extract is more concentrated but still chemically mixed. A pure compound, usually ibogaine hydrochloride, is a defined material that requires identity and purity testing.
Four changing forms
From living shrub to defined active compound
Each stage changes what is present, how variable it is, and what quality controls are needed. It also changes the ecological stakes around iboga.
02 · Variable
Raw bark
Dried root bark contains pigments, fats, tannins, and a changing total alkaloid profile, rather than a standardized dose of ibogaine.
03 · Concentrated
TA extract
A total alkaloid or TA extract retains multiple related alkaloids, including ibogamine and ibogaline, after solvent extraction.
04 · Defined
Ibogaine HCl
Purified freebase treated with hydrochloric acid can form ibogaine HCl, a white crystalline powder used in research settings.
Botanical origin
Tabernanthe iboga, the botanical origin
Anatomy of the iboga shrub and root bark
What plant does ibogaine naturally come from? The primary source is Tabernanthe iboga, a medicinal plant in the Apocynaceae family. It grows in rainforest regions of Gabon, the Republic of the Congo, and Cameroon, placing its botanical story firmly in Central Africa.
The shrub is commonly discussed for its root bark because that material holds the strongest relevant alkaloid concentration. Tabernanthe iboga generally needs five to seven years of growth before root alkaloids reach pharmacologically potent levels. This slow timeline makes mature plants unlike a rapidly replaceable crop.
Indigenous Bwiti communities in Gabon have used shaved inner root bark of iboga in spiritual rites and coming-of-age ceremonies for centuries. That history should not be compressed into a manufacturing input: iboga is also an entheogen and a cultural material within traditional medicine.
Other natural plant sources containing ibogaine
Other members of the Apocynaceae family may contain trace ibogaine-related alkaloids. Tabernaemontana undulata and Trachelospermum jasminoides are often noted, though yields are generally insufficient for industrial isolation. The central botanical source remains Tabernanthe iboga.
For general classification, the indole alkaloid reference helps situate ibogaine among plant-derived compounds whose chemical structures include an indole framework.
Process, not recipe
The chemical extraction process from root bark
Extraction is a technical separation process involving potent psychoactive alkaloids, hazardous materials, and a need for analytical verification. It is not suitable as a home procedure.
1. Preparing plant material
Harvested root bark may be separated, dried, and milled. Raw bark typically contains a total alkaloid concentration between two and six percent, with ibogaine comprising roughly half of that total alkaloid content. Concentrations vary with plant age, origin, storage, and processing.
2. Separating the alkaloids
In controlled laboratory work, acid-base extraction can isolate freebase indole alkaloids using dilute acids, non-polar organic solvents, and later neutralization. Solvent extraction and acid-base extraction remove some non-alkaloid plant constituents but do not automatically create a pure compound.
3. Purification and crystallization
Further purification separates ibogaine from ibogamine, ibogaline, and related compounds. Treating purified freebase material with hydrochloric acid can yield ibogaine hydrochloride, a water-soluble salt commonly described as a white crystalline powder after crystallization.
4. Testing before interpretation
Identity, concentration, residual organic solvents, contaminants, and related alkaloids need analytical assessment. A label such as “TA extract” does not establish equivalent purity, chemical structure, or bioavailability to ibogaine HCl.
“Plant origin” and “plant harvested for every dose” are different propositions.
Alternative precursor
Voacanga africana and semi-synthetic ibogaine
Commercial pharmaceutical ibogaine is frequently made through semi-synthesis using voacangine extracted from seeds and bark of Voacanga africana. This related Apocynaceae species provides a precursor rather than finished ibogaine.
Voacangine can undergo decarboxylation and demethylation reactions that yield pure ibogaine. This semi-synthetic route can reduce pressure on wild Tabernanthe iboga populations while retaining a plant-derived starting point.
A published account of biosynthesis of the anti-addiction agent illustrates the scientific interest in how nature assembles this unusual chemical structure.
Do not collapse categories
Differences between raw root bark, TA extract, and pure HCl
These forms share a relationship to iboga, but they are not chemically or pharmacologically identical. The distinction is essential when someone asks what ibogaine is made from.
Raw root bark
Raw bark is dried root material with variable quantities of ibogaine, other alkaloids, and non-alkaloid matter. It is a botanical mixture, not a pure active compound.
Total alkaloid extract
TA extract is concentrated through extraction, yet it can include ibogaine, ibogamine, ibogaline, and other alkaloids. Its composition depends on purification choices and plant material.
Ibogaine hydrochloride
Ibogaine HCl is a salt form of a purified compound. Hydrochloride formation can improve handling and water solubility, but its quality still depends on purity testing and controlled production.
People comparing formats and practical considerations may encounter information on ibogaine treatment costs in Mexico; the important starting point is that price or format alone cannot demonstrate quality, safety profile, or medical suitability.
After ingestion
Conversion of ibogaine to noribogaine in the body
Ibogaine does not remain chemically static after ingestion. In the liver, hepatic metabolism through the cytochrome P450 enzyme CYP2D6 converts a portion of ibogaine into noribogaine, its primary active metabolite. Differences in CYP2D6 activity can affect pharmacokinetics, exposure, and risk.
Noribogaine has a prolonged reported half-life of roughly 24 to 48 hours and is described as a potent serotonin reuptake inhibitor and kappa-opioid receptor agonist. Ibogaine also interacts with NMDA receptors and nicotinic acetylcholine receptors, and research has examined possible links with GDNF expression.
This pharmacology is one reason a simple “plant medicine” label is incomplete. The active compound, its metabolite, serotonin and dopamine systems, multiple receptors, liver metabolism, and co-medications can all influence a person’s response.
A peer-reviewed pharmacology record provides a useful entry point for examining why noribogaine is considered separately from ibogaine in scientific discussion.
Plant stewardship
Ecological sustainability and conservation of iboga
Growing demand connected to addiction therapy has increased pressure on wild Tabernanthe iboga across equatorial forests of Central Africa. Root harvesting can kill a shrub, which makes sustainable harvesting, replanting, cultivation, and traceability more meaningful than a generic natural-product label.
Poaching and poorly documented trade can undermine both conservation and the rights of communities connected to iboga. Gabon has identified Tabernanthe iboga as protected national cultural heritage and has enacted restrictions around raw botanical material exports.
International access and benefit-sharing conversations are tied to the Nagoya Protocol framework, which addresses genetic resources and equitable benefit-sharing. Its relevance is practical: botanical sourcing is also a question of stewardship and consent.
For a detailed account of the subject’s cultural and industrial passage, see the long roots of ibogaine. Semi-synthesis from voacangine may help reduce direct harvesting pressure, though it does not remove the need for transparent sourcing of Voacanga africana.
Practical questions
Plant, compound, and evidence
Answers below distinguish botanical identity from clinical claims and manufacturing terminology.
What plant does ibogaine naturally come from?
Ibogaine is primarily found in the root bark of Tabernanthe iboga, a shrub native to Gabon, Cameroon, and the Republic of the Congo in Central Africa. The plant belongs to the Apocynaceae family and is associated with Bwiti traditions in Gabon.
How is ibogaine extracted from plant roots?
Professional extraction begins with prepared plant material and uses chemical separation, often described as acid-base extraction and solvent extraction, before purification. The process can involve hydrochloric acid and organic solvents, potent psychoactive alkaloids, contamination risk, and legal restrictions; it should not be treated as a home method.
Can ibogaine be made synthetically without iboga plants?
Yes. Total synthesis can make ibogaine in a laboratory without harvesting iboga plants, although chemical synthesis can be complex. UC Davis researchers reported a total synthesis achievement that may expand routes for studying this compound.
Why is Voacanga africana used to produce ibogaine?
Voacanga africana contains voacangine, a precursor that can be converted through semi-synthesis to ibogaine. This route may limit direct depletion of wild Tabernanthe iboga, while still requiring attention to sourcing and conservation.
What is the difference between iboga root bark and pure ibogaine HCl?
Root bark is a variable botanical mixture. TA extract is a concentrated but mixed total alkaloid product. Ibogaine HCl is a purified hydrochloride salt with a more defined chemical structure, commonly presented as crystalline powder. Neither a label nor a claimed format establishes purity by itself.
What are the major safety considerations?
Ibogaine and noribogaine can be associated with cardiotoxicity, including QT prolongation and dangerous arrhythmias. Drug interactions, electrolyte status, underlying cardiac conditions, CYP2D6 variation, and uncertain product purity are material concerns. The legislative analysis of ibogaine underscores why policy attention includes research controls and safety questions.
About this resource
Clarity is part of the plant-to-compound story.
Ibogaine Origins Project is a newly launched independent information company helping people understand what is known, what is uncertain, and why the source material matters. See how this independent resource approaches evidence before drawing conclusions from botanical or clinical claims.
For additional context on current research discussion, the Stanford ibogaine study summary is one example of why careful interpretation is more useful than hype.
Explore plant and harvest context →For further context, see ibogaineclinic.com/what-is-ibogaine-made-from, www.akjournals.com/view/journals/2054/10/3/article-p222.xml, www.mindscaperetreat.com/what-is-ibogaine, lettersandsciencemag.ucdavis.edu/science-technology/uc-davis-researchers-achieve.